Educational resources are an essential component of the mission of PCSK9 Forum to increase awareness and understanding of PCSK9 science and therapeutics.

PCSK9 Forum has recently launched a series of educational slide decks analysing key results from important trials in the PCSK9 field. As a follow-on to the first slide decks which focus on the landmark FOURIER and ODYSSEY OUTCOMES studies, further decks discuss recent analyses from these trials.

A key analysis investigated the clinical benefit of evolocumab in patients with peripheral artery disease, a group shown to be at very high cardiovascular risk.

The effect of alirocumab on total events, including mortality, was discerned in subsequent key analyses.

Check back here to review these unique educational resources – and don’t forget to bookmark this page for updates to this programme.